Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mouse gut metagenome

ABSTRACT: Antibiotics in early life alter the gut microbiome and increase the incidence of type 1 diabetes

PROVIDER: PRJNA254809 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR1513310.fastq.gz	Fastqsanger.gz
	SRR1513340.fastq.gz	Fastqsanger.gz
	SRR1513470.fastq.gz	Fastqsanger.gz
	SRR1514150.fastq.gz	Fastqsanger.gz
	SRR1514160.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 36

Similar Datasets

The effect of antibiotic mediated gut microbiome perturbation on ileal gene expression in NOD mice.

Project description:The early life microbiome plays important roles in host immunological and metabolic development. Because type 1 diabetes (T1D) incidence has been increasing substantially in recent decades, we hypothesized that early-life antibiotic use alters gut microbiota that predisposes to disease. Using NOD mice that are genetically susceptible to T1D, we examined the effects of exposure to either continuous low-dose antibiotics or pulsed therapeutic antibiotics (PAT) early in life, mimicking childhood exposures. We found that in mice receiving PAT, T1D incidence was significantly higher, microbial community composition and structure differed compared with controls. In pre-diabetic male PAT mice, the intestinal lamina propria had lower Th17 and T reg proportions and intestinal SAA expression than in controls, suggesting key roles in transducing the altered microbiota signals. PAT affected microbial lipid metabolism and host cholesterol biosynthetic gene expression. These findings show that early-life antibiotic treatments alter the gut microbiota and its metabolic capacities, intestinal gene expression, and T-cell populations, accelerating T1D onset in NOD mice.

2016-05-20 | GSE81648 | GEO

mouse gut metagenome

Project description:The effects of subtherapeutic antibiotics on the murine colonic microbiome and early life adiposity

| PRJNA168618 | ENA

Mus musculus

Project description:Subtherapeutic antibiotics alter the murine colonic microbiome and early life adiposity

| PRJNA169135 | ENA

mouse gut metagenome

Project description:Early supplementation of human milk oligosaccharides suppresses spontaneous autoimmune diabetes in NOD mice later in life

| PRJNA362610 | ENA

mouse gut metagenome

Project description:Gastrointestinal microbiota in early life and antibiotic mice

| PRJNA770920 | ENA

mouse gut metagenome

Project description:Identification of a type 1 diabetes associated core microbiome

| PRJNA396656 | ENA

mouse gut metagenome

Project description:Mouse gut metagenome in early life exposure to cyanotoxin.

| PRJNA843121 | ENA

Mouse gut metagenome

Project description:Gut Microbiota-Immune System Modulation in Type 1 Diabetes Models

| PRJNA989542 | ENA

The balance between protective and pathogenic immune responses to pneumonia in the neonatal lung enforced by the gut microbiota

Project description:Although modern clinical practices such as cesarean sections and perinatal antibiotics have improved infant survival, treatment with broad-spectrum antibiotics alters intestinal microbiota and causes dysbiosis. Infants exposed to perinatal antibiotics have an increased likelihood of life-threatening infections, including pneumonia. Here, we investigated how the gut microbiota sculpt pulmonary immune responses, promoting recovery and resolution of infection in newborn rhesus macaques. Early-life antibiotic exposure interrupted the maturation of intestinal commensal bacteria and disrupted the developmental trajectory of the pulmonary immune system, as assessed by single-cell proteomic and transcriptomic analyses. Early-life antibiotic exposure rendered newborn macaques more susceptible to bacterial pneumonia, concurrent with increases in neutrophil senescence and hyperinflammation, broad inflammatory cytokine signaling, and macrophage dysfunction. This pathogenic reprogramming of pulmonary immunity was further reflected by a hyperinflammatory signature in all pulmonary immune cell subsets coupled with a global loss of tissue-protective, homeostatic pathways in the lungs of dysbiotic newborns. Fecal microbiota transfer was associated with partial correction of the broad immune maladaptations and protection against severe pneumonia. These data demonstrate the importance of intestinal microbiota in programming pulmonary immunity and support the idea that gut microbiota promote the balance between pathways driving tissue repair and inflammatory responses associated with clinical recovery from infection in infants. Our results highlight a potential role for microbial transfer for immune support in these at-risk infants.

2022-06-15 | GSE176408 | GEO

Project description:Fecal microbiota in early life and effects of early life antibiotics

| PRJNA612836 | ENA